| ［1］ Yang XJ, Huang CQ, Suo T, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase Ⅲ randomized clinical trial［J］. Ann Surg Oncol, 2011, 18(6): 15751581. DOI: 10.1245/s1043401116315.
［2］ Turrini O, Lambaudie E, Faucher M, et al. Initial experience with hyperthermic intraperitoneal chemotherapy［J］. Arch Surg, 2012, 147(10): 919923. DOI: 10.1001/archsurg.2012.988.
［3］ 吴印兵, 巴明臣, 崔书中, 等. 持续循环腹腔热灌注化疗治疗恶性腹水的临床应用初探［J］. 中国医学工程, 2013, 21(3): 68.
［4］ Tentes AA, Kakolyris S, Kyziridis D, et al. Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy in the treatment of advanced epithelial ovarian cancer［J］. J Oncol, 2012, 2012: 358341. DOI: 10.1155/2012/358341.
［5］ 任春振, 曹军丽, 胡宗兰, 等. 腹腔热灌注联合静脉化疗治疗晚期卵巢癌的临床观察［J］. 中国肿瘤临床, 2010, 37(24): 14591461. DOI: 10.3969/j.issn.10008179.2010.24.022.
［6］ 傅军民, 杨兰平. 热灌注化疗治疗卵巢癌并腹腔积液疗效观察［J］. 现代中西医结合杂志, 2013, 22(36): 40194021. DOI: 10.3969/j.issn.10088849.2013.36.012.
［7］ 邹庆伟, 蒲艳, 蒲敏. 腹腔热灌注联合全身静脉化疗在胃癌术后应用的效果观察［J］. 中国医疗前沿, 2013, 8(5): 6768. DOI: 10.3969/j.issn.16735552.2013.05.0041. |
